The Italian Council of State confirms the €180 million fine imposed on a pharmaceutical cartel for entering into an anticompetitive agreement by object (Hoffman-La Roche / Novartis)

On July 17th, the Council of State dismissed the appeals presented by F. Hoffman-La Roche Ltd. and Roche S.p.A. ("Roche") and from Novartis Farma S.p.A. and Novartis AG ("Novartis") against the judgement issued by Regional Administrative Court of First Instance rejecting the appeals against the Decision of the Italian Competition Authority ("AGCM"), which fined Roche and Novartis approximately €90 million each. Background Avastin was developed by a subsidiary of Roche and marketed by Roche

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Federico Marini Balestra, The Italian Council of State confirms the €180 million fine imposed on a pharmaceutical cartel for entering into an anticompetitive agreement by object (Hoffman-La Roche / Novartis), 15 July 2019, e-Competitions July 2019, Art. N° 94246

Visites 17

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues